Arteriosclerosis, Thrombosis, and Vascular Biology

Source: Wikipedia, the free encyclopedia.
Arteriosclerosis, Thrombosis, and Vascular Biology
OCLC no.
31441121
Links

Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) is a peer-reviewed medical journal published on behalf of the American Heart Association by Lippincott Williams & Wilkins, an imprint of Wolters Kluwer. It covers basic and clinical research related to vascular biology, pathophysiology and complications of atherosclerosis, and thrombotic mechanisms in blood vessels.

The journal was established in 1981 as Arteriosclerosis (

ISSN 1049-8834).[1]

According to the Journal Citation Reports, the journal has a 2020 impact factor of 8.311,[2] ranking it 8th in the category "Hematology"[2] and 5th in the category "Peripheral Vascular Disease".[2] Alan Daugherty has been the editor-in-chief since 2012.[3]

Open access option

ATVB offers an open access option for full-length, original contributions.[4] The corresponding author may select an open access option during the first submission of the manuscript. All articles published under open access license will incur an article processing charge, with three open access options available.[5]

All ATVB papers are available for free, full-text access after a 12-month

American Stroke Association
, or a paid subscription.

References

  1. National Library of Medicine
    online catalog. Accessed 2009-08-31.
  2. ^ a b c 2020 Journal Citation Reports. (Clarivate Analytics, 2021).
  3. ^ "About Arteriosclerosis, Thrombosis, and Vascular Biology". American Heart Association.
  4. ^ Open Access Information
  5. ^ "Publishing Costs, By Type of Agreement" (PDF). Archived from the original (PDF) on 2018-01-12. Retrieved 2018-01-11.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Arteriosclerosis,_Thrombosis,_and_Vascular_Biology&oldid=1152307779"